Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Loretta A. Carson is active.

Publication


Featured researches published by Loretta A. Carson.


Transfusion | 2001

Transfusion‐transmitted bacterial infectionin the United States, 1998 through 2000

Matthew J. Kuehnert; Virginia Roth; N. Rebecca Haley; Kay R. Gregory; Kathy V. Elder; George B. Schreiber; Matthew J. Arduino; Stacey C. Holt; Loretta A. Carson; Shailen N. Banerjee; William R. Jarvis

BACKGROUND: Bacterial contamination of blood components can result in transfusion‐transmitted infection, but the risk is not established.


The New England Journal of Medicine | 2001

Control of Vancomycin-Resistant Enterococcus in Health Care Facilities in a Region

Belinda E. Ostrowsky; William E. Trick; Annette H. Sohn; Stephen B. Quirk; Stacey C. Holt; Loretta A. Carson; Bertha C. Hill; Matthew J. Arduino; Matthew J. Kuehnert; William R. Jarvis

BACKGROUND In late 1996, vancomycin-resistant enterococci were first detected in the Siouxland region of Iowa, Nebraska, and South Dakota. A task force was created, and in 1997 the assistance of the Centers for Disease Control and Prevention was sought in assessing the prevalence of vancomycin-resistant enterococci in the regions facilities and implementing recommendations for screening, infection control, and education at all 32 health care facilities in the region. METHODS The infection-control intervention was evaluated in October 1998 and October 1999. We performed point-prevalence surveys, conducted a case-control study of gastrointestinal colonization with vancomycin-resistant enterococci, and compared infection-control practices and screening policies for vancomycin-resistant enterococci at the acute care and long-term care facilities in the Siouxland region. RESULTS Perianal-swab samples were obtained from 1954 of 2196 eligible patients (89 percent) in 1998 and 1820 of 2049 eligible patients (89 percent) in 1999. The overall prevalence of vancomycin-resistant enterococci at 30 facilities that participated in all three years of the study decreased from 2.2 percent in 1997 to 1.4 percent in 1998 and to 0.5 percent in 1999 (P<0.001 by chi-square test for trend). The number of facilities that had had at least one patient with vancomycin-resistant enterococci declined from 15 in 1997 to 10 in 1998 to only 5 in 1999. At both acute care and long-term care facilities, the risk factors for colonization with vancomycin-resistant enterococci were prior hospitalization and treatment with antimicrobial agents. Most of the long-term care facilities screened for vancomycin-resistant enterococci (26 of 28 in 1998 [93 percent] and 23 of 25 in 1999 [92 percent]) and had infection-control policies to prevent the transmission of vancomycin-resistant enterococci (22 of 25 [88 percent] in 1999). All four acute care facilities had screening and infection-control policies for vancomycin-resistant enterococci in 1998 and 1999. CONCLUSIONS An active infection-control intervention, which includes the obtaining of surveillance cultures and the isolation of infected patients, can reduce or eliminate the transmission of vancomycin-resistant enterococci in the health care facilities of a region.


The New England Journal of Medicine | 1987

Mycobacterium chelonae Wound Infections after Plastic Surgery Employing Contaminated Gentian Violet Skin-Marking Solution

Thomas J. Safranek; William R. Jarvis; Loretta A. Carson; Lucy Cusick; Lee A. Bland; Jana M. Swenson; Vella A. Silcox

From April 1 to October 31, 1985, postoperative surgical-wound infections due to rapidly growing mycobacteria developed in eight patients undergoing cosmetic plastic surgery performed by one surgeon. All infections followed either face-lift or augmentation-mammoplasty procedures performed in the surgeons office; no infections occurred after surgical procedures performed at the hospital or after other surgical procedures performed at the office. An epidemiologic investigation implicated a gentian violet skin-marking solution as the source of the infections (P less than 0.001). Among patients exposed to the gentian violet, infection was significantly more likely to develop in those undergoing a face lift or augmentation mammoplasty than in those undergoing blepharoplasty (P less than 0.001). Additional risk factors for infection included the postoperative use of antibiotics and glucocorticoids. Mycobacterium chelonae, subspecies abscessus, was isolated from the gentian violet stock used by the surgeon and from five of the eight patients. Additional studies showed that the same organism was present in the gentian violet stock at the pharmacy that supplied the agent to the surgeon. After a sterile skin-marking agent was substituted for the contaminated agent, no further cases occurred.


Science | 1971

Pseudomonas aeruginosa: growth in distilled water from hospitals.

Favero Ms; Loretta A. Carson; WalterW. Bond; Petersen Nj

Pseudomonas aeruginosa can grow relatively fast in distilled water obtained in hospitals and achieve high cell contaminations which remain stable for long periods of time. Cells grown in distilled water react quite differently to chemical and physical stresses than cells grown in standard laboratory culture media.


The New England Journal of Medicine | 2001

SERRATIA LIQUEFACIENS BLOODSTREAM INFECTIONS FROM CONTAMINATION OF EPOETIN ALFA AT A HEMODIALYSIS CENTER

Lisa A. Grohskopf; Virginia R. Roth; Daniel R. Feikin; Matthew J. Arduino; Loretta A. Carson; Jerome I. Tokars; Stacey C. Holt; Bette Jensen; Richard E. Hoffman; William R. Jarvis

BACKGROUND In a one month period, 10 Serratia liquefaciens bloodstream infections and 6 pyrogenic reactions occurred in outpatients at a hemodialysis center. METHODS We performed a cohort study of all hemodialysis sessions on days that staff members reported S. liquefaciens bloodstream infections or pyrogenic reactions. We reviewed procedures and cultured samples of water, medications, soaps, and hand lotions and swabs from the hands of personnel. RESULTS We analyzed 208 sessions involving 48 patients. In 12 sessions, patients had S. liquefaciens bloodstream infections, and in 8, patients had pyrogenic reactions without bloodstream infection. Sessions with infections or reactions were associated with higher median doses of epoetin alfa than the 188 other sessions (6500 vs. 4000 U, P=0.03) and were more common during afternoon or evening shifts than morning shifts (P=0.03). Sessions with infections or reactions were associated with doses of epoetin alfa of more than 4000 U (multivariate odds ratio, 4.0; 95 percent confidence interval, 1.3 to 12.3). A review of procedures revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and residual epoetin alfa from multiple vials was pooled and administered to patients. S. liquefaciens was isolated from pooled epoetin alfa, empty vials of epoetin alfa that had been pooled, antibacterial soap, and hand lotion. All the isolates were identical by pulsed-field gel electrophoresis. After the practice of pooling epoetin alfa was discontinued and the contaminated soap and lotion were replaced, no further S. liquefaciens bloodstream infections or pyrogenic reactions occurred at this hemodialysis facility. CONCLUSIONS Puncturing single-use vials multiple times and pooling preservative-free epoetin alfa caused this outbreak of bloodstream infections in a hemodialysis unit. To prevent similar outbreaks, medical personnel should follow the manufacturers guidelines for the use of preservative-free medications.


Pediatric Infectious Disease Journal | 1998

Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners.

Lawrence C. Mcdonald; Mary Walker; Loretta A. Carson; Matthew J. Arduino; Sonia M. Aguero; Perry Gomez; Percival Mcneil; William R. Jarvis

BACKGROUND Acinetobacter spp. are multidrug-resistant bacteria that grow well in water and cause infections with unexplained, increased summer prevalence. In August, 1996, eight infants acquired Acinetobacter spp. bloodstream infection (A-BSI) while in a nursery in the Bahamas; three infants died and an investigation was initiated. METHODS A case patient was defined as any newborn in the nursery during August 6 to 13, 1996, with A-BSI. To identify risk factors for A-BSI we conducted a retrospective cohort study and performed environmental cultures and air sampling using settle plates. The genetic relatedness of environmental isolates was assessed by pulsed field gel electrophoresis. RESULTS Of 33 patients in the nursery 8 (24%) met the case definition. Patients with peripheral iv catheters were more likely to develop A-BSI (8 of 21 vs. O of 10, P < 0.05). Multivariate analysis among patients with iv catheters indicated that only exposure to one nurse was an independent risk factor for developing A-BSI (P < 0.005). Nursery settle plates were more likely to grow Acinetobacter spp. than were settle plates from other hospital areas (8 of 9 vs. 0 of 5, P < 0.005); cultures from nursery air conditioners also grew Acinetobacter spp. Environmental isolates were genetically diverse. After installation of a new air conditioner in May, 1995, A-BSIs occurred more frequently during months of increased absolute humidity or environmental dew point. CONCLUSIONS Acinetobacter spp. may cause nosocomial BSI and death among infants during periods of polyclonal airborne dissemination; breaks in aseptic technique during i.v. medication administration may facilitate transmission from the environment to the patient. Environmental conditions that increase air conditioner condensate may predispose to airborne dissemination via contaminated aerosols and increase the risk of nosocomial A-BSI.


The Journal of Pediatrics | 1994

Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis

David A. Pegues; Loretta A. Carson; Ofelia C. Tablan; Stacey C. FitzSimmons; Susan B. Roman; J. Michael Miller; William R. Jarvis

To assess the risk of acquisition of Pseudomonas cepacia by person-to-person transmission at cystic fibrosis summer camps, we conducted in 1990 a study at three camps attended by patients with cystic fibrosis who had P. cepacia infection and patients without P. cepacia infection but who were considered susceptible to infection. We obtained sputum or throat cultures from campers on their arrival at, weekly during, at the end of, and 14 to 30 days after camp. We compared the incidence of sputum conversion of patients at camp with that of patients outside camp by culturing specimens from noncamper control subjects with cystic fibrosis who were known not to be infected < or = 2 weeks before and 4 to 6 weeks after camp. We also determined the risk factors for P. cepacia acquisition by determining the relative risk of acquisition between campers who were exposed versus campers who were not exposed to campers known to be infected or to potential environmental sources of P. cepacia at camp. The ribotype of P. cepacia isolates from campers with sputum conversion was compared with that of isolates from other campers and from an environmental source. The cumulative incidence of sputum conversion during the study period was 6.1% (11/181) among campers compared with no incidence (0/92) among noncampers (p = 0.02, Fisher Exact Test). The incidence of sputum conversion at camp varied according to the prevalence of campers with known infection (p < 0.001, chi-square test for trend). The rate of sputum conversion was higher in the camp with longer duration (relative risk = 12.0; 95% confidence interval = 2.7 to 53.5). Ribotyping showed that P. cepacia isolates from all 11 campers with sputum conversion were identical or similar (1 to 2 band difference) to isolates of other P. cepacia-infected campers including co-converters. These results suggest that P. cepacia can be acquired by patients with cystic fibrosis who are attending summer camp for such patients, possibly through person-to-person transmission, and that the risk increases with the prevalence of P. cepacia-infected campers and the duration of camp.


The Journal of Infectious Diseases | 1999

Regional Dissemination of Vancomycin-Resistant Enterococci Resulting from Interfacility Transfer of Colonized Patients

William E. Trick; Matthew J. Kuehnert; Stephen B. Quirk; Matthew J. Arduino; Sonia M. Aguero; Loretta A. Carson; Bertha C. Hill; Shailen N. Banerjee; William R. Jarvis

During early 1997, the Siouxland District Health Department (SDHD; Sioux City, IA) reported an increased incidence of vancomycin-resistant enterococcal (VRE) isolates at area health care facilities. To determine the prevalence and risk factors for colonization with VRE strains at 32 health care facilities in the SDHD region, a prevalence survey and case-control study were performed. Of 2266 patients and residents, 1934 (85%) participated, and 40 (2.1%) were positive for (gastrointestinal) VRE colonization. The prevalence of VRE isolates was significantly higher in acute care facilities (ACFs) than in long-term care facilities (LTCFs) (10/152 [6.6%] vs. 30/1782 [1.7%]; odds ratio [OR], 4.1; 95% confidence interval [CI], 1.8-9.0). LTCF case patients were significantly more likely than controls to have been inpatients at any ACF (19/30 vs. 12/66; OR, 8.0; 95% CI, 2.7-23.8). Of 40 VRE isolates, 34 (85%) were a related strain. The predominant strain was present in all 12 LTCFs that had at least 1 case patient in each facility. Soon after the introduction of VRE isolates into this region, dissemination to multiple LTCFs resulted from resident transfer from ACFs to LTCFs.


Infection Control and Hospital Epidemiology | 2000

Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community hospital: a role for species and strain identification.

Soon Duck Kim; L. Clifford McDonald; William R. Jarvis; Sigrid K. McAllister; Robert Jerris; Loretta A. Carson; J. Michael Miller

OBJECTIVES To determine the degree to which species identification or strain relatedness assessment of successive blood culture isolates of coagulase-negative staphylococci (CNS) may improve the clinical diagnosis of bloodstream infection (BSI). SETTING 400-bed community hospital. DESIGN Prospective laboratory survey during which all CNS blood culture isolates obtained between mid-August 1996 and mid-February 1997 (study period) were saved and later identified to the species level; selected isolates were genotyped using pulsed-field gel electrophoresis at the Centers for Disease Control and Prevention (CDC). Retrospective review of medical records of 37 patients with multiple cultures positive for CNS. RESULTS During the study period, 171 patients had blood cultures positive for CNS; 130 had single positive cultures and 41 had > or =2 positive cultures. Of these 41, 23 (62%) were from patients with signs and symptoms of BSI according to CDC surveillance definitions. Species identification and strain clonality of CNS isolates from patients with > or =2 positives revealed 3 (13%) of the 23 patients did not have a consistent CNS species, and another 3 (13%) did not have a consistent genotype in the > or =2 positive cultures, suggesting that CNS from these patients probably were contaminants. Thus, species identification and strain clonality assessment reduced by 27% the number of patients with BSI diagnosed based on the presence of symptoms and > or =2 positive blood cultures. CONCLUSIONS Routine species identification and selected strain genotyping of CNS may reduce the misinterpretation of probable contaminants among patients with > or =2 positive blood cultures.


Transfusion | 2000

Transfusion-related sepsis due to Serratia liquefaciens in the United States

Virginia R. Roth; Matthew J. Arduino; J. Nobiletti; Stacey C. Holt; Loretta A. Carson; C.F.W. Wolf; B.A. Lenes; P.M. Allison; William R. Jarvis

BACKGROUND: Severe, often fatal, transfusion reactions due to bacterial contamination of blood components continue to occur. Serratia liquefaciens, an unusual human pathogen, is a recently recognized potential cause of transfusion‐related sepsis.

Collaboration


Dive into the Loretta A. Carson's collaboration.

Top Co-Authors

Avatar

William R. Jarvis

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Matthew J. Arduino

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Stacey C. Holt

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sonia M. Aguero

United States Department of Health and Human Services

View shared research outputs
Top Co-Authors

Avatar

Jerome I. Tokars

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

David A. Pegues

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

J. Michael Miller

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Matthew J. Kuehnert

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Belinda E. Ostrowsky

Virginia Commonwealth University

View shared research outputs
Top Co-Authors

Avatar

Lee A. Bland

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge